1033463-30-7

Basic information

• Product Name: 3-chloro-5-(trifluoromethyl)-2-pyridinecarbohydrazide
• Synonyms: 3-chloro-5-(trifluoromethyl)-2-pyridinecarbohydrazide
• CAS NO: 1033463-30-7
• Molecular Formula: C7H5ClF3N3O
• Molecular Weight: 239.5823096
• Mol File: 1033463-30-7.mol
• Article Data: 4

Chemical Properties

• Melting Point: 105-107°
• Appearance: /
• CAS DataBase Reference: 3-chloro-5-(trifluoromethyl)-2-pyridinecarbohydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-5-(trifluoromethyl)-2-pyridinecarbohydrazide(1033463-30-7)
• EPA Substance Registry System: 3-chloro-5-(trifluoromethyl)-2-pyridinecarbohydrazide(1033463-30-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 1033463-30-7(Hazardous Substances Data)

Upstream product

• 128073-16-5 3-chloro-5-trifluoromethylpyridine-2-carboxylic acid ethyl ester 
• 80194-72-5 3-chloro-5-trifluoromethyl-2-pyridinecarboxylic acid chloride 

Relevant articles and documents

AZEPIN-2-ONE DERIVATIVES AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

ARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof, which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.